Iron oxide nanoparticles have emerged as a versatile family of functional nanomaterials capable of addressing diverse challenges across clinical medicine, industrial biotechnology, and environmental remediation. In a comprehensive narrative review analyzing literature published between 2010 and 2025 across PubMed, Web of Science, and Scopus, researchers synthesized the fundamental physical principles, chemical synthesis methodologies, surface engineering strategies, and translational diagnostic and therapeutic applications of these materials. Iron oxide nanoparticles encompass several key polymorphs, notably magnetite, maghemite, and mixed ferrites, which display unique ferrimagnetic crystal architectures. When these particles are engineered at the nanoscale, their physical dimensions allow thermal energy at room temperature to overcome magnetic anisotropy energy barriers, establishing superparamagnetic behavior that eliminates remanent magnetization and coercivity when an external magnetic field is deactivated.
The structural characteristics of iron oxide polymorphs dictate their intrinsic magnetic ordering and subsequent utility in biological environments. Magnetite possesses an inverse spinel crystal structure containing both divalent and trivalent iron cations, producing an antiparallel sublattice alignment that yields a net ferrimagnetic moment of approximately 4.1 Bohr magnetons per formula unit at 300 Kelvin, persisting up to its Verwey transition at roughly 120 Kelvin. Maghemite maintains a cubic spinel arrangement with ordered cation vacancies that yields a saturation magnetization near 380 kiloamperes per meter and a Curie temperature around 950 Kelvin. Other variants, such as the metastable orthorhombic epsilon polymorph, present giant coercivity exceeding one Tesla, while rhombohedral hematite functions primarily as an antiferromagnet with weak canted ferromagnetism. The critical superparamagnetic threshold is governed by the Néel-Arrhenius relation and empirical blocking criteria, corresponding under quasi-static measurement conditions to room-temperature critical diameters between 24 and 26 nanometers for magnetite and 34 to 37 nanometers for maghemite.
Precise control over nanoparticle dimensions, geometry, and monodispersity is achieved through distinct chemical preparation routes that account for roughly ninety percent of established fabrication techniques. The co-precipitation technique represents one of the most accessible and scalable methods, generating substantial quantities of spherical nanoparticles through the alkaline precipitation of aqueous iron salts at elevated temperatures. In contrast, thermal decomposition relies on heating organometallic precursors or iron salts in organic solvents between 200 and 400 degrees Celsius, granting tight control over crystal growth, particle size distributions, and morphological anisotropy. Sol-gel synthesis enables the formation of inorganic networks through controlled hydrolysis and polycondensation, yielding xerogels that can be vacuum-annealed to generate crystallized magnetite suitable for thin-film fabrication and catalytic systems. Microemulsion systems utilize thermodynamically stable dispersions of water-in-oil or oil-in-water nanoreactors regulated by surfactants to produce highly uniform crystallites.
In response to demands for environmentally conscious fabrication, green synthesis protocols have emerged as viable alternatives to conventional chemical pathways by eliminating hazardous synthetic reducing agents. Green routes employ aqueous plant extracts rich in bioactive phytochemicals, including polyphenols, flavonoids, terpenoids, and phenolic acids, to reduce iron ions and cap developing nanocrystals. In typical protocols, washed and powdered plant foliage is boiled in deionized water, concentrated, and combined with iron salts such as ferric chloride hexahydrate under alkaline conditions at room temperature to induce nanoparticle formation. Following magnetic stirring, separation by centrifugation, and thermal drying, the resulting iron oxide nanoparticles exhibit reduced intrinsic chemical toxicity, lower energy consumption profiles during production, and surface coatings directly functionalized with naturally derived organic moieties.
Surface engineering represents an essential requirement for translating pristine iron oxide nanoparticles into viable biomedical tools, as bare metallic cores are prone to oxidation, agglomeration, and rapid clearance. Inorganic surface coatings provide robust physical barriers that enhance chemical stability and biological tolerance while mitigating in situ degradation. Silica encapsulation, commonly implemented via the Stöber method or microemulsion processing, creates a hydrophilic shell that prevents core aggregation and provides an adaptable matrix for chemical conjugation. Carbon coatings formed via pyrolysis or chemical vapor deposition introduce chemical passivity against oxidative degradation alongside electrical conductivity. Furthermore, shell deposition using noble metals such as gold, silver, or platinum imparts plasmonic, optical, and catalytic functionality, enabling dual-modality tracking and specialized surface attachment.
Organic surface modifications rely on hydrophilic polymers to confer steric stabilization, extend vascular circulation lifetimes, and govern biodistribution profiles within living tissues. Biocompatible macromolecules including polyethylene glycol, dextran, chitosan, polyvinyl alcohol, polyvinylpyrrolidone, alginate, and polydopamine can be integrated via in situ coating or post-synthesis functionalization. Polyethylene glycol polymers substantially diminish reticuloendothelial system recognition and enhance renal clearance. Branched polymers such as polyethyleneimine provide dense cationic charges that facilitate high-capacity electrostatic binding and stabilization of nucleic acids for therapeutic delivery. Natural biopolymers like chitosan and alginate provide water solubility and biodegradability for drug transport, although researchers note that dextran coatings have exhibited dose-dependent neurotoxicity in cultured neuronal models, underscoring the critical necessity of systematic biocompatibility evaluations.
In vitro and in vivo toxicological analyses demonstrate that nanoparticle biocompatibility depends heavily on shape, geometric scale, surface charge, and exposure concentration. Morphological variations, including nanocubes, nanorods, nano-octahedrons, nanoflowers, and nanorings, display divergent endocytosis rates and cellular tolerances. Experiments assessing cellular viability via metabolic proliferation assays demonstrate that bare and polymer-coated iron oxide nanoparticles generally maintain cell viability rates above ninety percent at concentrations below 100 micrograms per milliliter across varied epithelial, fibroblast, and tumor cell cultures. Nanoparticles engineered with dimensions near 10 to 30 nanometers avoid immediate splenic filtration and rapid hepatic extraction, prolonging systemic bioavailability. Conversely, larger assemblies exceeding 200 nanometers face swift capture by splenic macrophages, while unfunctionalized surfaces with high positive or negative charges experience accelerated clearance through the mononuclear phagocyte system.
Diagnostic imaging represents one of the most mature applications for superparamagnetic iron oxide nanoparticles, capitalizing on their capability to dramatically shorten transverse proton relaxation times during magnetic resonance imaging. By decreasing relaxation parameters, these contrast agents induce pronounced hypointense signal loss on T2- and T2*-weighted scans. Formulations ranging from 50 to 150 nanometers undergo preferential uptake by hepatic macrophages, establishing visual contrast between healthy liver parenchyma and macrophage-depleted neoplastic lesions such as hepatocellular carcinomas and metastatic growths. Ultrasmall variants measuring 20 to 30 nanometers circulate through vascular channels and accumulate within functional lymph node macrophages, facilitating precise staging of malignant invasions in prostate and colorectal cancers. Magnetic resonance angiography employing iron oxide contrast agents can similarly identify vascular endoleaks following aortic stent procedures without exposing patients to ionizing radiation.
Beyond diagnostic radiology, iron oxide nanoparticles are deployed across advanced therapeutic platforms, biosensing systems, and environmental separation processes. In targeted cancer therapy, nanoparticles functionalized with chemotherapeutic compounds such as doxorubicin or paclitaxel enable localized drug release triggered by magnetic fields or acidic tumor microenvironments. Under alternating high-frequency magnetic fields, magnetic hysteretic losses generate localized hyperthermia exceeding 42 degrees Celsius to destroy malignant cells. The compound ferumoxytol is clinically approved by regulatory authorities for managing iron deficiency anemia in adult patients suffering from chronic kidney disease by replenishing macrophage iron stores. In bioengineering, iron oxide nanoparticles act as artificial nanozymes with peroxidase-like activity to power non-enzymatic glucose, cholesterol, and metabolite biosensors, while their strong magnetic susceptibility enables rapid cell sorting via magnetic-activated cell sorting, crude protein purification, and magnetic contaminant extraction during wastewater remediation.
Despite substantial clinical promise, significant biological limitations continue to hinder the widespread translational adoption of diverse iron oxide nanoformulations. Intravenously administered nanoparticles accumulate predominantly within reticuloendothelial tissues, with hepatic structures sequestering over half of the injected dose within six hours. Excess intracellular iron accumulation can exceed cellular storage capacities, driving Fenton-type catalytic reactions that generate destructive reactive oxygen species, induce oxidative stress, and compromise mitochondrial membrane integrity. Furthermore, PEGylated formulations can persist in tissues for several weeks, raising safety concerns regarding chronic organ inflammation. The review concludes that bridging the gap toward wider clinical integration requires rational structural engineering targeting stimuli-responsive degradation, ultra-small sub-six-nanometer diameters for direct renal elimination, and the establishment of standardized long-term toxicological safety protocols evaluating systemic clearance beyond sixty days.
Subject of Research: Synthesis, surface modification, and biomedical applications of iron oxide nanoparticles
Article Title: Advances in the synthesis, properties, and applications of iron oxide nanoparticles
Article References: Farooqui, M., Abid, A., Khan, R., Choudhary, F., Sharma, P., Safdar, A., & Farooqi, H. (2026). Advances in the synthesis, properties, and applications of iron oxide nanoparticles. Discover Sensors, 2(1), Article 12. https://doi.org/10.1007/s44397-026-00043-3
Image Credits: AI Generated
DOI: 10.1007/s44397-026-00043-3
Keywords: iron oxide nanoparticles, superparamagnetism, nanomedicine, co-precipitation, thermal decomposition, sol-gel synthesis, green synthesis, surface modification, biocompatibility, magnetic resonance imaging, targeted drug delivery, magnetic particle imaging, hyperthermia therapy, ferumoxytol, ferrimagnetic materials, nanobiotechnology
News Source: Denise Maddox. (November 14, 2026). Iron Oxide Nanoparticles Show Broad Versatility in Biomedical and Sensing Technologies. Scienmag.



